HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dannielle Zierath Selected Research

Myelin Basic Protein

1/2017Splenectomy Does Not Improve Long-Term Outcome After Stroke.
1/2016Antibodies to myelin basic protein are associated with cognitive decline after stroke.
8/2015Promiscuity of autoimmune responses to MBP after stroke.
10/2013The immunologic profile of adoptively transferred lymphocytes influences stroke outcome of recipients.
1/2013Severe stroke induces long-lasting alterations of high-mobility group box 1.
11/2012Myelin basic protein autoantibodies, white matter disease and stroke outcome.
11/2010Anamnestic recall of stroke-related deficits: an animal model.
4/2010CNS immune responses following experimental stroke.
10/2009Long term immunologic consequences of experimental stroke and mucosal tolerance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dannielle Zierath Research Topics

Disease

18Stroke (Strokes)
11/2018 - 10/2009
6Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2018 - 10/2009
6Ischemic Stroke
05/2014 - 12/2011
4Inflammation (Inflammations)
11/2018 - 09/2012
4Infections
01/2016 - 04/2011
3Infarction (Infarctions)
01/2017 - 02/2011
2Pneumonia (Pneumonitis)
01/2016 - 08/2014
1Status Epilepticus (Complex Partial Status Epilepticus)
01/2021
1Lymphopenia (Lymphocytopenia)
03/2018
1Cognitive Dysfunction
01/2016
1Brain Injuries (Brain Injury)
08/2015
1Fatigue
03/2015
1Leukoencephalopathies
11/2012
1Brain Ischemia (Cerebral Ischemia)
02/2011
1Hypersensitivity (Allergy)
11/2010

Drug/Important Bio-Agent (IBA)

9Myelin Basic ProteinIBA
01/2017 - 10/2009
7AntigensIBA
11/2018 - 10/2009
3Biomarkers (Surrogate Marker)IBA
11/2018 - 01/2013
3Hydrocortisone (Cortisol)FDA LinkGeneric
03/2018 - 04/2011
2C-Reactive ProteinIBA
11/2018 - 09/2012
2Adrenocorticotropic Hormone (ACTH)FDA Link
03/2018 - 12/2011
2Interleukin-6 (Interleukin 6)IBA
03/2018 - 12/2011
2ceftiofurIBA
01/2016 - 08/2015
2EnrofloxacinIBA
01/2016 - 08/2015
2Anti-Bacterial Agents (Antibiotics)IBA
01/2016 - 08/2015
2AntibodiesIBA
01/2016 - 11/2012
2AutoantibodiesIBA
01/2016 - 11/2012
2Biological ProductsIBA
03/2015 - 10/2014
2CytokinesIBA
10/2014 - 04/2011
2Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
08/2014 - 04/2011
2Melanocyte-Stimulating Hormones (MSH)IBA
12/2011 - 02/2011
2LipopolysaccharidesIBA
11/2010 - 04/2010
1Kainic Acid (Kainate)IBA
01/2021
1Oxidopamine (6 Hydroxydopamine)IBA
11/2018
1Labetalol (Normodyne)FDA LinkGeneric
11/2018
1Adrenergic Agents (Adrenergic Drugs)IBA
11/2018
1salicylhydroxamic acid (SHAM)IBA
01/2017
1OvalbuminIBA
08/2015
1LactamsIBA
08/2015
1FluoroquinolonesIBA
08/2015
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
08/2014
1Toll-Like Receptor 4IBA
05/2014
1Toll-Like Receptors (Toll-Like Receptor)IBA
02/2014
1PeroxiredoxinsIBA
02/2014
1HMGB1 Protein (HMG1)IBA
01/2013
1Proteins (Proteins, Gene)FDA Link
11/2012
1Immunoglobulin G (IgG)IBA
11/2012
1Tetanus Toxoid (Vaccine, Tetanus)FDA Link
11/2012
1Chemokine CX3CL1IBA
09/2012
1Interleukin-10 (Interleukin 10)IBA
04/2011
1Hormones (Hormone)IBA
04/2011
1NeuropeptidesIBA
02/2011
1alpha-MSHIBA
02/2011
1lipoteichoic acidIBA
04/2010
1staphylococcal enterotoxin BIBA
04/2010

Therapy/Procedure

4Therapeutics
01/2016 - 04/2011
1Chemical Sympathectomy
11/2018
1Splenectomy
01/2017
1Intraperitoneal Injections
04/2010